Thanksgiving is just around the corner, and with all the excitement of gathering with family and friends, finding the perfect ...

Maze’s IPO comes on the heels of its oversubscribed Series D funding round, which infused the biotech with $115 million in funding to support the development of its kidney disease pipeline. Following ...